{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-049451","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.557235+00:00","generated_at":"2026-05-20T04:17:22.569771+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adial Pharmaceuticals receives Nasdaq delisting notice for equity below $2.5M minimum","bullets":["Stockholders' equity of $2,126,662 as of March 31, 2025, below Nasdaq's $2.5M requirement.","Company has 45 calendar days (until July 7, 2025) to submit a compliance plan to Nasdaq.","If plan accepted, Nasdaq may grant up to 180 days extension to regain compliance.","Failure to regain compliance could lead to delisting; company may request a hearing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-049451","json":"https://secwatch.observer/filing/0001213900-25-049451.json","markdown":"https://secwatch.observer/filing/0001213900-25-049451.md","text":"https://secwatch.observer/filing/0001213900-25-049451.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025049451/0001213900-25-049451-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025049451/ea0243908-8k_adial.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:17:22.569771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"129db63f0bee18abdca5bccd925371ce11d18e6a","claim":"ADIAL PHARMACEUTICALS, INC. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"May 23, 2025, Adial Pharmaceuticals, Inc. (the “Company”), received a letter from The Nasdaq Stock Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (the “Rule”) because the stockholders’ equity of the Company of $2,126,662 as of March 31, 2025, as reported in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 14, 2025, was below the minimum requirement of $2,500,000. As of the date of this Current Report on Form 8-K, the Company does not have a market value of listed securities of $35 million, or net income from continued o","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390025049451/0001213900-25-049451-index.htm","confidence":0.97,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"noncompliance notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}